Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Saved in:
Bibliographic Details
Title: Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.
Authors: Rangel-Peláez C; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Rodriguez-Martin I; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Rosa-Baez C; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Kerick M; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Guillén-Del-Castillo A; Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Simeón-Aznar CP; Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Callejas JL; Systemic Autoimmune Disease Unit, Hospital Clínico San Cecilio, Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain., Distler O; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Proudman SM; Rheumatology Unit, Royal Adelaide Hospital and the University of Adelaide, Adelaide, South Australia, Australia., Nikpour M; Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia.; Faculty of Medicine and Health, The University of Sydney School of Public Health, Sydney, New South Wales, Australia., Hunzelmann N; Department of Dermatology and Venereology, University Hospital Cologne, Cologne, Germany., Moroncini G; Department of Clinical and Molecular Science, Marche Polytechnic University, Ancona, Italy.; Department of Internal Medicine, Marche University Hospital, Ancona, Italy., de Vries-Bouwstra JK; The Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., Herrick AL; Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Allanore Y; Department of Rheumatology, Université Paris Cité UFR de Médecine, Paris, France., Alarcón-Riquelme ME; Centre for Genomics and Oncological Research, Pfizer, University of Granada/Andalusian Regional Government, Spain, Granada., Beretta L; Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy., Mayes MD; UT Health Houston, Division of Rheumatology, McGovern Medical School, Houston, TX, USA., Denton CP; Centre for Rheumatology, Royal Free Hospital, UCL, London, UK., Assassi S; UT Health Houston, Division of Rheumatology, McGovern Medical School, Houston, TX, USA., Martín J; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Acosta-Herrera M; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain., Ortiz-Fernández L; Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.
Corporate Authors: and the International SSc Group, the PRECISESADS Clinical Consortium, and the Australian Scleroderma Interest Group (ASIG)#
Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 May 05; Vol. 65 (5).
Publication Type: Journal Article; Meta-Analysis
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1462-0332
DOI:10.1093/rheumatology/keag164